fda drug shortages semaglutide injection shortage resolved 2025 Announces End to of Products (Ozempic, Wegovy) The GLP-1 drug shortage is

Initially developed for managing type 2 diabetes, semaglutide has since been approved for weight loss and is now widely prescribed for both conditions

Having a trusted source makes it easier to run consistent research without delays or uncertainty

Many patients begin noticing changes within the first few weeks when treatment is combined with healthy dietary changes and regular physical activity

One benefit of a personalized program using compounded medications is the ability to work closely with a provider on a titration schedule that fits your bodys unique response

Because it works on many systems in the body, it can have wider effects , both good and bad